Endpoint protection, often abbreviated as EPP, is a system designed to secure each endpoint of an enterprise network from potential cyber threats. It's a security approach that focuses on each device ...
This article is part of a VB special issue. Read the full series here: Intelligent Security Achieving greater visibility and control over endpoints is table stakes for any organization pursuing ...
GlobalData on MSN
OS endpoint focus will realign industry to “ultimate goal”
While OS is still the king of the oncology endpoints, experts note it may soon be phased out due to the introduction of ...
The age of hybrid work is here. 76% of companies say they have shifted to a hybrid work strategy, splitting work hours between an office and remote environment. Only 11% of teams say they’re planning ...
MSK played a central role in the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC)’s landmark decision in April 2024 to accept measurable residual disease (MRD) as an ...
Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more Bad actors continue to capitalize on the ...
The rapid pace of digital transformation has increased operational efficiency and enhanced the customer experience – but it has also created a nightmare for CISOs. From mobile devices scattered across ...
Privosegtor (also known as OCS-05) is a “first-in-class peptoid small molecule” for neuroprotective therapy for acute optic ...
Enata Pharmaceuticals said it didn't meet its primary endpoint in a Phase 2b study of zelicapavir, its proposed treatment for Respiratory Syncytial Virus, or RSV, in high-risk adults.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results